A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma

Patient: Male, 31 Final Diagnosis: Light chain depsotion disease Symptoms: — Medication: — Clinical Procedure: None Specialty: Hematology Objective: Rare co-existance of disease or pathology Background: Light chain deposition disease is a systemic disease characterized by deposition of immunoglobin light chains in various organs. Cardiac involvement of light chain deposition disease, also known as cardiac nonamyloidotic immunoglobin deposition disease (CIDD), is a rare clinical entity, where clinical outcome is very variable and best treatment approaches are not well known. Case Report: We present the case of a 31-year-old man with a solitary thoracic plasmacytoma and cardiac light chain deposition disease with evidence of congestive heart failure by echocardiography and cardiac markers. The patient underwent surgical resection of the plasmacytoma followed by systemic therapy with 50% VDT-PACE and then VRD with near-normalization of his heart function. A melphalan-based stem cell transplant is planned in this young patient to achieve the best possible long-term remission. Conclusions: CIDD is a very rare disease, with previous reports showing diverse manifestations with variable outcome. A high level of clinical suspicion should be maintained in such cases and early intervention, as in our patient, can restore cardiac function. There is very little literature on the optimal management of these patients. A combination of surgery and chemotherapy were pursued in our patient with very good results.

[1]  D. Dingli,et al.  Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis , 2013, Bone Marrow Transplantation.

[2]  P. L. Bergsagel,et al.  Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. , 2012, Blood.

[3]  D. Dingli,et al.  Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Dimopoulos,et al.  Treatment of light chain deposition disease with bortezomib and dexamethasone , 2009, Haematologica.

[5]  V. D’Agati,et al.  A case of atypical light chain deposition disease--diagnosis and treatment. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[6]  B. Barlogie,et al.  Cardiac nonamyloidotic immunoglobulin deposition disease , 2006, Modern Pathology.

[7]  M. Grassi,et al.  Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient , 1998, The Italian Journal of Neurological Sciences.

[8]  F. Locatelli,et al.  Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  T. Masuda,et al.  Reversible restrictive cardiomyopathy due to light-chain deposition disease. , 2002, Mayo Clinic proceedings.

[10]  I. Kronzon,et al.  Infiltrative Nonamyloidotic Monoclonal Immunoglobulin Light Chain Cardiomyopathy: An Underappreciated Manifestation of Plasma Cell Dyscrasias , 2000, Cardiology.

[11]  Ramée,et al.  Congestive heart failure: revealing light chain deposition disease. , 2000, European journal of internal medicine.

[12]  E. Hatzimichael,et al.  A Patient with Multiple Myeloma, Amyloidosis and Light-Chain Deposition Disease in Kidneys with a Long Survival , 1999, Acta Haematologica.

[13]  C. Girelli,et al.  Kappa light chain deposition disease of the liver. , 1998, European journal of gastroenterology & hepatology.

[14]  A. Moreau,et al.  Lambda light chain deposition disease presenting as sicca syndrome. , 1997, Arthritis and rheumatism.

[15]  A. Berrebi,et al.  Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis. , 1995, The American journal of the medical sciences.

[16]  M. Mihatsch,et al.  Ocular Pathology in Light Chain Deposition Disease , 1995, European journal of ophthalmology.

[17]  S. Walton,et al.  Systemic lambda light-chain deposition presenting with predominant cardiac involvement. , 1993, Postgraduate medical journal.

[18]  J. Velosa,et al.  Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.